Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Harrow Comprehensive Income 2010-2024 | HROW

Harrow comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
  
Harrow Annual Comprehensive Income
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2009 $
Harrow Quarterly Comprehensive Income
(Millions of US $)
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.498B $0.130B
Harrow Inc. is an eyecare pharmaceutical company. It engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products principally for the U.S. market. Harrow Inc., formerly known as Harrow Health Inc., is based in NASHVILLE, Tenn.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $80.628B 31.03
Takeda Pharmaceutical (TAK) Japan $42.924B 8.93
Sandoz Group AG (SDZNY) Switzerland $19.692B 0.00
Merck (MKKGY) Germany $19.341B 17.32
Astellas Pharma (ALPMY) Japan $18.350B 16.90
United Therapeutics (UTHR) United States $16.459B 16.19
Summit Therapeutics (SMMT) United States $14.152B 0.00
Neurocrine Biosciences (NBIX) United States $12.870B 34.08
Shionogi (SGIOY) Japan $12.206B 11.69
Catalent (CTLT) United States $11.125B 0.00
Madrigal Pharmaceuticals (MDGL) United States $7.529B 0.00
Orion OYJ (ORINY) Finland $6.653B 18.71
Corcept Therapeutics (CORT) United States $6.185B 46.85
Ionis Pharmaceuticals (IONS) United States $5.599B 0.00
Crinetics Pharmaceuticals (CRNX) United States $5.202B 0.00
PTC Therapeutics (PTCT) United States $3.316B 0.00
Dyne Therapeutics (DYN) United States $2.997B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.597B 15.52
Catalyst Pharmaceuticals (CPRX) United States $2.527B 11.45
Soleno Therapeutics (SLNO) United States $2.467B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.255B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.945B 0.00
Xencor (XNCR) United States $1.824B 0.00
Evotec AG (EVO) Germany $1.733B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.720B 0.00
Guardian Pharmacy Services (GRDN) United States $1.551B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.506B 0.00
Indivior (INDV) United States $1.502B 6.12
Ocular Therapeutix (OCUL) United States $1.429B 0.00
ARS Pharmaceuticals (SPRY) United States $1.332B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.247B 0.00
Ardelyx (ARDX) United States $1.243B 0.00
Enliven Therapeutics (ELVN) United States $1.216B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.081B 0.00
Collegium Pharmaceutical (COLL) United States $0.993B 5.42
Bioventus (BVS) United States $0.933B 29.49
Cronos Group (CRON) Canada $0.814B 0.00
Relay Therapeutics (RLAY) United States $0.813B 0.00
USANA Health Sciences (USNA) United States $0.761B 14.11
Oruka Therapeutics (ORKA) United States $0.648B 0.00
Elite Pharmaceuticals (ELTP) United States $0.647B 0.00
Altimmune (ALT) United States $0.610B 0.00
Tourmaline Bio (TRML) United States $0.609B 0.00
OmniAb (OABI) United States $0.586B 0.00
Savara (SVRA) United States $0.585B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.536B 0.00
Organogenesis (ORGO) United States $0.536B 0.00
ProKidney (PROK) United States $0.534B 0.00
Siga Technologies (SIGA) United States $0.522B 6.09
Zevra Therapeutics (ZVRA) United States $0.507B 0.00
Esperion Therapeutics (ESPR) United States $0.506B 0.00
Korro Bio (KRRO) United States $0.487B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.466B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.460B 186.36
Xeris Biopharma Holdings (XERS) United States $0.459B 0.00
Verve Therapeutics (VERV) United States $0.448B 0.00
Aquestive Therapeutics (AQST) United States $0.439B 0.00
KalVista Pharmaceuticals (KALV) United States $0.435B 0.00
Akebia Therapeutics (AKBA) United States $0.421B 0.00
Larimar Therapeutics (LRMR) United States $0.404B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.388B 0.00
4D Molecular Therapeutics (FDMT) United States $0.352B 0.00
Avita Medical (RCEL) United States $0.343B 0.00
Sage Therapeutics (SAGE) United States $0.323B 0.00
Nature's Sunshine Products (NATR) United States $0.301B 17.91
Aldeyra Therapeutics (ALDX) United States $0.296B 0.00
Aclaris Therapeutics (ACRS) United States $0.285B 0.00
Lyell Immunopharma (LYEL) United States $0.255B 0.00
Lexeo Therapeutics (LXEO) United States $0.239B 0.00
Acrivon Therapeutics (ACRV) United States $0.223B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.219B 0.00
Silence Therapeutics (SLN) United Kingdom $0.216B 0.00
Cassava Sciences (SAVA) United States $0.207B 0.00
Nektar Therapeutics (NKTR) United States $0.201B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.191B 0.00
MediWound (MDWD) Israel $0.187B 0.00
Profound Medical (PROF) Canada $0.185B 0.00
Heron Therapeutics (HRTX) United States $0.173B 0.00
Galectin Therapeutics (GALT) United States $0.170B 0.00
Nanobiotix S.A (NBTX) France $0.165B 0.00
Inhibikase Therapeutics (IKT) United States $0.157B 0.00
Achieve Life Sciences (ACHV) Canada $0.155B 0.00
CytoDyn (CYDY) United States $0.144B 0.00
VAXART, INC (VXRT) United States $0.139B 0.00
Telomir Pharmaceuticals (TELO) United States $0.133B 0.00
Cardiol Therapeutics (CRDL) Canada $0.126B 0.00
Journey Medical (DERM) United States $0.120B 0.00
Pyxis Oncology (PYXS) United States $0.112B 0.00
Century Therapeutics (IPSC) United States $0.111B 0.00
Context Therapeutics (CNTX) United States $0.110B 0.00
Fractyl Health (GUTS) United States $0.109B 0.00
Karyopharm Therapeutics (KPTI) United States $0.105B 0.00
Innate Pharma SA (IPHYF) France $0.103B 0.00
Avalo Therapeutics (AVTX) United States $0.102B 0.00
Regulus Therapeutics (RGLS) United States $0.100B 0.00
Inotiv (NOTV) United States $0.098B 0.00
Assertio Holdings (ASRT) United States $0.096B 25.25
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Relmada Therapeutics (RLMD) United States $0.083B 0.00
PMV Pharmaceuticals (PMVP) United States $0.082B 0.00
Vivani Medical (VANI) United States $0.081B 0.00
OptiNose (OPTN) United States $0.080B 0.00
ESSA Pharma (EPIX) Canada $0.080B 0.00
Swiftmerge Acquisition (IVCP) United States $0.077B 0.00
Metagenomi (MGX) United States $0.075B 0.00
ElectroCore (ECOR) United States $0.074B 0.00
CASI Pharmaceuticals (CASI) China $0.066B 0.00
Mural Oncology (MURA) Ireland $0.066B 0.00
Scienture Holdings (SCNX) United States $0.066B 0.00
AlloVir (ALVR) United States $0.064B 0.00
Unicycive Therapeutics (UNCY) United States $0.057B 0.00
Champions Oncology (CSBR) United States $0.057B 0.00
Iterum Therapeutics (ITRM) Ireland $0.055B 0.00
Protara Therapeutics (TARA) United States $0.054B 0.00
BioVie (BIVI) United States $0.053B 0.00
Prelude Therapeutics (PRLD) United States $0.053B 0.00
Nutriband (NTRB) United States $0.053B 0.00
Gain Therapeutics (GANX) United States $0.048B 0.00
Rafael Holdings (RFL) United States $0.047B 0.00
SCYNEXIS (SCYX) United States $0.047B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.045B 0.00
VYNE Therapeutics (VYNE) United States $0.044B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.036B 0.00
Carisma Therapeutics (CARM) United States $0.035B 0.00
Incannex Healthcare (IXHL) Australia $0.035B 0.00
DURECT (DRRX) United States $0.030B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.030B 0.00
Surrozen (SRZN) United States $0.030B 0.00
Lipocine (LPCN) United States $0.027B 0.00
Natural Alternatives (NAII) United States $0.027B 0.00
CERo Therapeutics Holdings (CERO) United States $0.026B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
BioLineRx (BLRX) Israel $0.022B 0.00
GlycoMimetics (GLYC) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.018B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Vivos Therapeutics (VVOS) United States $0.016B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
NRx Pharmaceuticals (NRXP) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.014B 0.00
Traws Pharma (TRAW) United States $0.013B 0.00
Nuvilex (PMCB) United States $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Talphera (TLPH) United States $0.012B 0.00
Jaguar Animal Health (JAGX) United States $0.012B 0.00
Indaptus Therapeutics (INDP) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Redhill Biopharma (RDHL) Israel $0.010B 0.00
Dominari Holdings (DOMH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Conduit Pharmaceuticals (CDT) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Klotho Neurosciences (KLTO) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Aditxt (ADTX) United States $0.006B 0.00
Biomerica (BMRA) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Molecular Templates (MTEM) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Oncternal Therapeutics (ONCT) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 2.44
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 39.06